KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Teladoc Health (TDOC) Operating Income (2016 - 2025)

Teladoc Health's Operating Income history spans 12 years, with the latest figure at -$36.0 million for Q4 2025.

  • For Q4 2025, Operating Income rose 25.34% year-over-year to -$36.0 million; the TTM value through Dec 2025 reached -$263.0 million, up 74.24%, while the annual FY2025 figure was -$263.0 million, 74.24% up from the prior year.
  • Operating Income for Q4 2025 was -$36.0 million at Teladoc Health, up from -$52.0 million in the prior quarter.
  • Across five years, Operating Income topped out at -$35.1 million in Q4 2023 and bottomed at -$6.7 billion in Q1 2022.
  • The 5-year median for Operating Income is -$71.7 million (2022), against an average of -$772.6 million.
  • The largest annual shift saw Operating Income crashed 9109.86% in 2022 before it surged 99.08% in 2023.
  • A 5-year view of Operating Income shows it stood at -$41.4 million in 2021, then plummeted by 9109.86% to -$3.8 billion in 2022, then soared by 99.08% to -$35.1 million in 2023, then plummeted by 37.44% to -$48.2 million in 2024, then grew by 25.34% to -$36.0 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Operating Income are -$36.0 million (Q4 2025), -$52.0 million (Q3 2025), and -$54.4 million (Q2 2025).